Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Revenue 2010-2024 | MKKGY

Merck annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Merck revenue for the quarter ending September 30, 2024 was $5.790B, a 2.85% increase year-over-year.
  • Merck revenue for the twelve months ending September 30, 2024 was $22.740B, a 0.74% decline year-over-year.
  • Merck annual revenue for 2023 was $22.721B, a 3% decline from 2022.
  • Merck annual revenue for 2022 was $23.424B, a 0.57% increase from 2021.
  • Merck annual revenue for 2021 was $23.292B, a 16.29% increase from 2020.
  
Merck Annual Revenue
(Millions of US $)
2023 $22,721
2022 $23,424
2021 $23,292
2020 $20,029
2019 $18,090
2018 $17,521
2017 $17,324
2016 $16,626
2015 $14,254
2014 $15,288
2013 $14,738
2012 $14,369
2011 $13,799
2010 $12,338
2009 $10,807
Merck Quarterly Revenue
(Millions of US $)
2024-09-30 $5,790
2024-06-30 $5,764
2024-03-31 $5,559
2023-12-31 $5,628
2023-09-30 $5,630
2023-06-30 $5,781
2023-03-31 $5,682
2022-12-31 $5,817
2022-09-30 $5,848
2022-06-30 $5,925
2022-03-31 $5,833
2021-12-31 $5,977
2021-09-30 $5,864
2021-06-30 $5,868
2021-03-31 $5,583
2020-12-31 $5,474
2020-09-30 $5,199
2020-06-30 $4,535
2020-03-31 $4,821
2019-12-31 $4,864
2019-09-30 $4,508
2019-06-30 $4,464
2019-03-31 $4,255
2018-12-31 $4,196
2018-09-30 $4,359
2018-06-30 $4,429
2018-03-31 $4,537
2017-12-31 $4,549
2017-09-30 $4,380
2017-06-30 $4,280
2017-03-31 $4,115
2016-12-31 $4,128
2016-09-30 $4,156
2016-06-30 $4,298
2016-03-31 $4,043
2015-12-31 $3,795
2015-09-30 $3,489
2015-06-30 $3,560
2015-03-31 $3,464
2014-12-31 $3,398
2014-09-30 $3,896
2014-06-30 $3,827
2014-03-31 $3,654
2013-12-31 $3,729
2013-09-30 $3,645
2013-06-30 $3,769
2013-03-31 $3,581
2012-12-31 $3,646
2012-09-30 $3,555
2012-06-30 $3,520
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $3,677
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $3,145
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.882B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.684B 28.35
Chugai Pharmaceutical (CHGCY) Japan $69.441B 27.05
Takeda Pharmaceutical (TAK) Japan $41.205B 8.58
Sandoz Group AG (SDZNY) Switzerland $18.766B 0.00
Astellas Pharma (ALPMY) Japan $17.138B 15.78
United Therapeutics (UTHR) United States $16.294B 16.03
Neurocrine Biosciences (NBIX) United States $14.266B 37.77
Summit Therapeutics (SMMT) United States $13.163B 0.00
Shionogi (SGIOY) Japan $12.012B 12.03
Madrigal Pharmaceuticals (MDGL) United States $7.392B 0.00
Orion OYJ (ORINY) Finland $6.424B 18.06
Ionis Pharmaceuticals (IONS) United States $5.283B 0.00
Corcept Therapeutics (CORT) United States $5.223B 39.56
Grifols, S.A (GRFS) Spain $5.012B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.764B 0.00
PTC Therapeutics (PTCT) United States $3.389B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.688B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.614B 11.85
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
NewAmsterdam Pharma (NAMS) Netherlands $2.305B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.062B 0.00
Soleno Therapeutics (SLNO) United States $1.859B 0.00
Indivior (INDV) United States $1.634B 6.66
Dyne Therapeutics (DYN) United States $1.615B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
Evotec AG (EVO) Germany $1.545B 0.00
Xencor (XNCR) United States $1.442B 0.00
Harrow (HROW) United States $1.306B 0.00
Ocular Therapeutix (OCUL) United States $1.291B 0.00
Guardian Pharmacy Services (GRDN) United States $1.266B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.155B 0.00
ARS Pharmaceuticals (SPRY) United States $1.092B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 5.79
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Cronos Group (CRON) Canada $0.757B 0.00
Bioventus (BVS) United States $0.753B 23.79
Relay Therapeutics (RLAY) United States $0.745B 0.00
USANA Health Sciences (USNA) United States $0.646B 11.97
Ironwood Pharmaceuticals (IRWD) United States $0.634B 0.00
Oruka Therapeutics (ORKA) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.507B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Altimmune (ALT) United States $0.489B 0.00
OmniAb (OABI) United States $0.486B 0.00
Savara (SVRA) United States $0.477B 0.00
ProKidney (PROK) United States $0.472B 0.00
Verve Therapeutics (VERV) United States $0.468B 0.00
Esperion Therapeutics (ESPR) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.443B 5.17
Zevra Therapeutics (ZVRA) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.432B 0.00
KalVista Pharmaceuticals (KALV) United States $0.388B 0.00
Akebia Therapeutics (AKBA) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Korro Bio (KRRO) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.294B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.286B 116.07
Jupiter Neurosciences (JUNS) United States $0.283B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 15.63
4D Molecular Therapeutics (FDMT) United States $0.255B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Heron Therapeutics (HRTX) United States $0.236B 0.00
Larimar Therapeutics (LRMR) United States $0.234B 0.00
Profound Medical (PROF) Canada $0.227B 0.00
Lexeo Therapeutics (LXEO) United States $0.211B 0.00
Inhibikase Therapeutics (IKT) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.190B 0.00
CytoDyn (CYDY) United States $0.183B 0.00
MediWound (MDWD) Israel $0.180B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
Silence Therapeutics (SLN) United Kingdom $0.179B 0.00
Lyell Immunopharma (LYEL) United States $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.176B 0.00
Acrivon Therapeutics (ACRV) United States $0.170B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.144B 0.00
Cassava Sciences (SAVA) United States $0.136B 0.00
Nanobiotix S.A (NBTX) France $0.133B 0.00
Champions Oncology (CSBR) United States $0.131B 0.00
Telomir Pharmaceuticals (TELO) United States $0.122B 0.00
Metagenomi (MGX) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Inotiv (NOTV) United States $0.114B 0.00
ElectroCore (ECOR) United States $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Regulus Therapeutics (RGLS) United States $0.092B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Century Therapeutics (IPSC) United States $0.084B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Journey Medical (DERM) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.080B 20.91
ESSA Pharma (EPIX) Canada $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Galectin Therapeutics (GALT) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
FibroGen (FGEN) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
AleAnna (ANNA) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
OptiNose (OPTN) United States $0.053B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.052B 0.00
AlloVir (ALVR) United States $0.051B 0.00
VYNE Therapeutics (VYNE) United States $0.051B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Scienture Holdings (SCNX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.040B 0.00
BioVie (BIVI) United States $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Incannex Healthcare (IXHL) Australia $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Traws Pharma (TRAW) United States $0.024B 0.00
DURECT (DRRX) United States $0.024B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SciSparc (SPRC) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Conduit Pharmaceuticals (CDT) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.98